
Global venture capital partnership investing in data, technology and analytics companies, backed by RELX Group

Stem cell and drug discovery research company supplying iPSC tools, human tissue testing and clinical services

ReproCELL is a research company that supplies products and services for stem cell science, preclinical drug testing and clinical development. Scientists around the world use its offerings to move laboratory findings towards therapies.
Cell therapy developers, stem cell researchers, preclinical and clinical drug developers, and diagnostic developers.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
As of 2026-10-05. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about ReproCELL.
Similar listings buyers compare against this one.

Global venture capital partnership investing in data, technology and analytics companies, backed by RELX Group

Crypto and blockchain investor backing multi-stage Web3 companies worldwide, part of CTH

Early-stage venture firm backing pre-seed and seed founders in Canada and the US

Enlightenment Capital

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Technology investor backing fast-growing, high-margin companies in fintech and other large markets
Everything here links back to the same verified catalogue. Pick your next stop.